Skip to main content
Top
Published in: Abdominal Radiology 7/2021

01-07-2021 | Esophagography | Practice

Adapting the modified barium swallow: modifications to improve safety in the setting of airborne respiratory illnesses like COVID-19

Authors: Alice R. Goldman, Jay K. Pahade, Nicole A. Langton-Frost, Chiquacta A. Hodges, Amy M. Taylor, Gregory Bova, Javad R. Azadi

Published in: Abdominal Radiology | Issue 7/2021

Login to get access

Abstract

No guidance exists on how to safely perform modified barium swallows (MBS) in the midst of the COVID-19 pandemic or other communicable airborne respiratory infections (C-ARI). MBS has the potential to become an aerosol generating procedure (AGP) as it may trigger a cough or necessitate suctioning which may result in transmission of C-ARI putting patients and health care workers at risk. Regulations and best practices from international and US governmental and commercial agencies were reviewed. This review led to the multidisciplinary development of best practices of the safety measures and structural requirements to avoid transmission of SARS-CoV-2 or other C-ARIs when performing MBS. Implementation of these best practices resulted in structural changes to the fluoroscopy suite and protocol workflows. This enabled patients with COVID-19 to undergo MBS while maintaining patient and staff safety including mitigation of potential risk of onward transmission of SARS-CoV-2 to other patients. With proper modifications, MBS can be safely performed on patients with C-ARI such as COVID-19 while maintaining patient and health care worker (HCW) safety.
Literature
2.
go back to reference Mossa-Basha M, Azadi J, Ko J, Klein J, Meltzer C, Force C-T (2020) RSNA COVID-19 Task Force: Best Practices for Radiology Departments during COVID-19. http://Rsna.org/COVID-19. Accessed 20 Aug 2020 Mossa-Basha M, Azadi J, Ko J, Klein J, Meltzer C, Force C-T (2020) RSNA COVID-19 Task Force: Best Practices for Radiology Departments during COVID-19. http://​Rsna.​org/​COVID-19. Accessed 20 Aug 2020
10.
go back to reference American Society of Heating Refrigerating and Air-Conditioning Engineers Inc. (2017) ANSI/ASHRAE/ASHE Standard 170–2017. Ventilation Of Health Care Facilities. American Society of Heating Refrigerating and Air-Conditioning Engineers Inc. (2017) ANSI/ASHRAE/ASHE Standard 170–2017. Ventilation Of Health Care Facilities.
11.
go back to reference Center for Disease Control and Prevention (2020) Table B.1. Air changes/hour (ACH) and time required for airborne-contaminant removal by efficiency *. Center for Disease Control and Prevention (2020) Table B.1. Air changes/hour (ACH) and time required for airborne-contaminant removal by efficiency *.
Metadata
Title
Adapting the modified barium swallow: modifications to improve safety in the setting of airborne respiratory illnesses like COVID-19
Authors
Alice R. Goldman
Jay K. Pahade
Nicole A. Langton-Frost
Chiquacta A. Hodges
Amy M. Taylor
Gregory Bova
Javad R. Azadi
Publication date
01-07-2021
Publisher
Springer US
Published in
Abdominal Radiology / Issue 7/2021
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-021-03025-8

Other articles of this Issue 7/2021

Abdominal Radiology 7/2021 Go to the issue

Classics in Abdominal Radiology

The cracked ice ball

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine